RJ Coffey, EB Leof, GD Shipley, HL Moses - Journal of cellular physiology, 1987 - interscience.wiley.com Suramin, a polyanionic compound, has previously been shown to dissociate
platelet-derived growth factor (PDGF) from its receptor. In the present study
suramin was found to inhibit the growth of sparse cultures of AKR-2B cells ... Cited by 247 - Related articles - All 4 versions
- ►ascopubs.org [PDF] CA Stein, RV LaRocca, R Thomas, N McAtee, … - Journal of Clinical Oncology, 1989 - jco.ascopubs.org From the Medicine Branch, Clinical Oncology Program, National Cancer Institute,
National Institutes of Health, Bethesda, MD. Submitted August 9, 1988; accepted
November 21, 1988. Address reprint requests to Charles E. Myers, MD, Medi- ... Cited by 245 - Related articles - All 5 versions
- ►hematologylibrary.org AM Levine, L Seneviratne, BM Espina, AR … - Blood, 2000 - bloodjournal.hematologylibrary.org Over time, the epidemiologic and demographic characteristics of AIDS have
changed in the United States. The prevalence of AIDS has increased among
minority populations, in women, and in those who acquired HIV by ... Cited by 121 - Related articles - BL Direct - All 6 versions
- ►jbc.org [PDF] M Nakajima, A DeChavigny, CE Johnson, J … - Journal of Biological Chemistry, 1991 - ASBMB Suramin, a polysulfonated naphthylurea, has anti- reverse transcriptase and
anti-proliferative activities and inhibits the binding of various growth factors
to their cell surface receptors. This drug is used in the treatment of ... Cited by 116 - Related articles - All 4 versions
- ►oxfordjournals.org [PDF] MA Eisenberger, LM Reyno, DI Jodrell, VJ … - JNCI Journal of the National Cancer Institute, 1993 - jnci.oxfordjournals.org Background: Previous studies indicate that suramin may be an active agent for
treatment of solid tumors. The clinical use of suramin is complicated by a broad
spectrum of toxic effects and complex pharmacology. Studies have suggested ... Cited by 106 - Related articles - BL Direct - All 8 versions
BD Cheson, AM Levine, D Mildvan, LD Kaplan, … - Jama, 1987 - Am Med Assoc Suramin sodium is a reverse transcriptase inhibitor with in vitro activity
against the human immunodeficiency virus (HIV), the causative agent of acquired
immunodeficiency syndrome (AIDS). Ninety-eight patients with AIDS manifest ... Cited by 57 - Related articles - All 4 versions
- ►physiology.org YS Chan, Y Li, W Foster, T Horaguchi, G … - Journal of Applied Physiology, 2003 - Am Physiological Soc Muscle injuries are very common in traumatology and sports medicine. Although
muscle tissue can regenerate postinjury, the healing process is slow and often
incomplete; complete recovery after skeletal muscle injury is hindered by ... Cited by 44 - Related articles - BL Direct - All 5 versions
- ►jcojournal.org [PDF] PJ Rosen, EF Mendoza, EM Landaw, B Mondino … - Journal of Clinical Oncology, 1996 - jcojournal.org Purpose: To confirm the previously reported high re- sponse rates and prolonged
survival in hormone-refractory prostate cancer treated with suramin. Patients
and Methods: Thirty-six eligible patients with hormone-refractory prostate ... Cited by 40 - Related articles - BL Direct - All 7 versions
YS Chan, Y Li, W Foster, FH Fu, J Huard - The American journal of sports medicine, 2005 - ajsm.highwire.org Materials and Methods: In vitro, muscle-derived fibroblasts (a potential cell
source of muscle fibrosis) were incubated with suramin and/or transforming
growth factor–β1; a cell growth curve was obtained. In vivo, mouse ... Cited by 39 - Related articles - All 10 versions
M Reincke, C Heppner, F Petzke, B Allolio, … - Neuroimmunomodulation, 1994 - content.karger.com African sleeping sickness (SS) is a severe, potentially lethal parasitic
disease. The treatments of choice are the antiparasitic agents suramin, which is
adrenotoxic, and/or melarsoprol. We evaluated the functional integrity of ... Cited by 38 - Related articles - All 4 versions
